{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003232","form_type":"8-K","ticker":"COCP","cik":"0001412486","company_name":"Cocrystal Pharma, Inc.","filed_at":"2025-04-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.210866+00:00","generated_at":"2026-05-23T18:58:04.806193+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Cocrystal Pharma adopts 2025 Equity Incentive Plan with 1.5M initial shares","bullets":["Plan effective March 31, 2025; shareholder approval required under Nasdaq rules.","Initially authorizes 1,500,000 shares of common stock for awards.","Annual increase on Jan 1 each year: 5% of outstanding shares, up to 2,500,000 per year (total cap 4,000,000).","Plan expires March 31, 2035; awards can include options, SARs, restricted stock, RSUs, performance shares/units, cash.","No specific officer/director grants announced; plan is broad-based for employees, consultants, directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003232","json":"https://secwatch.observer/filing/0001641172-25-003232.json","markdown":"https://secwatch.observer/filing/0001641172-25-003232.md","text":"https://secwatch.observer/filing/0001641172-25-003232.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225003232/0001641172-25-003232-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225003232/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T18:58:04.806193+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}